# Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc. is a company headquartered in Durham, NC, United States.

## Company overview

- **Legal name:** Satsuma Pharmaceuticals, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Durham, NC, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001692830

## About

Satsuma Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001692830, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-28, it reported net income of USD -70,055,000; total assets of USD 54,939,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$70.1M (USD -70,055,000)
- **Total assets:** $54.9M (USD 54,939,000)
- **Cash and equivalents:** $16.4M (USD 16,429,000)
- **Operating cash flow:** -$51.5M (USD -51,516,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$51.2M (USD -51,172,000)
- **Total assets:** $109.8M (USD 109,832,000)
- **Cash and equivalents:** $15.8M (USD 15,835,000)
- **Operating cash flow:** -$43.0M (USD -42,997,000)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$47.6M (USD -47,563,000)
- **Total assets:** $81.0M (USD 81,033,000)
- **Cash and equivalents:** $36.3M (USD 36,326,000)
- **Operating cash flow:** -$42.3M (USD -42,327,000)

### FY2019 (period ended 2019-12-31)

- **Net income:** -$28.2M (USD -28,175,000)
- **Total assets:** $126.3M (USD 126,276,000)
- **Cash and equivalents:** $22.8M (USD 22,755,000)
- **Operating cash flow:** -$29.6M (USD -29,637,000)

## Recent SEC filings

- Form 8-K — filed 2023-06-08 — period 2023-06-06 — 8-K
- Form 8-K — filed 2023-05-18 — period 2023-05-18 — 8-K
- Form 10-Q — filed 2023-05-11 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-03 — period 2023-05-01 — 8-K
- Form 10-K/A — filed 2023-04-28 — period 2022-12-31 — 10-K/A
- Form 8-K — filed 2023-04-17 — period 2023-04-11 — 8-K
- Form 10-K — filed 2023-03-28 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-03-28 — period 2023-03-28 — 8-K
- Form 8-K — filed 2023-02-16 — period 2023-02-16 — 8-K
- Form 8-K — filed 2022-12-20 — period 2022-12-20 — 8-K
- Form 8-K — filed 2022-11-30 — period 2022-11-30 — 8-K
- Form SC 13G — filed 2022-11-16 — NONE

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/satsuma-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology